Vivimed Labs Ltd
VIVIMEDLAB
Company Profile
Business description
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments, the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
Contact
Green Lands, Beside The Plaza Hotel
D.No.6-3-866/1/G1, 3rd & 4th Floor, GMR Towers
Begumpet
HyderabadTG500016
INDT: +91 4066086608
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
650
Stocks News & Analysis
stocks
Distribution growth for ASX income play
Cost containment and growing revenue bode well for profit margins.
stocks
We take a different view to market on ASX bloodbath
Sales growth at CSL was lower than expected but streamlining the business has its perks.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,265.20 | 32.60 | 0.35% |
| CAC 40 | 7,973.03 | 6.05 | -0.08% |
| DAX 40 | 24,276.97 | 146.10 | -0.60% |
| Dow JONES (US) | 44,938.31 | 16.04 | 0.04% |
| FTSE 100 | 9,288.14 | 98.92 | 1.08% |
| HKSE | 25,141.61 | 24.33 | -0.10% |
| NASDAQ | 21,172.86 | 142.09 | -0.67% |
| Nikkei 225 | 42,606.36 | 282.19 | -0.66% |
| NZX 50 Index | 13,194.07 | 122.77 | 0.94% |
| S&P 500 | 6,395.78 | 15.59 | -0.24% |
| S&P/ASX 200 | 9,000.60 | 26.90 | 0.30% |
| SSE Composite Index | 3,785.21 | 19.00 | 0.50% |